Article
Pea‐derived vaccines demonstrate high immunogenicity and protection in rabbits against rabbit haemorrhagic disease virus
21 May 2009
Abstract excerpt
Vaccines against rabbit haemorrhagic disease virus (RHDV) are commercially produced in experimentally infected rabbits. A genetically engineered and manufactured version of the major structural protein of RHDV (VP60) is considered to be an alternative approach for vaccine production. Plants have the potential to become an excellent recombinant production system, but the low expression level and insufficient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
